Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RPS6KA3 anticorps

RPS6KA3 Reactivité: Humain WB, ELISA, FACS, ICC Hôte: Souris Monoclonal 4-00E-10 unconjugated
N° du produit ABIN969386
  • Antigène Voir toutes RPS6KA3 Anticorps
    RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
    Reactivité
    • 181
    • 125
    • 65
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 181
    • 16
    • 1
    Souris
    Clonalité
    • 183
    • 15
    Monoclonal
    Conjugué
    • 66
    • 13
    • 9
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 3
    • 2
    Cet anticorp RPS6KA3 est non-conjugé
    Application
    • 90
    • 68
    • 67
    • 53
    • 28
    • 24
    • 17
    • 15
    • 12
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Purification
    purified
    Immunogène
    Purified recombinant fragment of human RSK2 expressed in E. coli.
    Clone
    4-00E-10
    Isotype
    IgG1
  • Indications d'application
    ELISA: 1:10000, WB: 1:500 - 1:2000, ICC: 1:200 - 1:1000, FCM: 1:200 - 1:400
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    4°C, -20°C for long term storage
  • Dehan, Bassermann, Guardavaccaro, Vasiliver-Shamis, Cohen, Lowes, Dustin, Huang, Taunton, Pagano: "betaTrCP- and Rsk1/2-mediated degradation of BimEL inhibits apoptosis." dans: Molecular cell, Vol. 33, Issue 1, pp. 109-16, (2009) (PubMed).

    Cho, Yao, Pugliese, Malakhova, Bode, Dong: "A regulatory mechanism for RSK2 NH(2)-terminal kinase activity." dans: Cancer research, Vol. 69, Issue 10, pp. 4398-406, (2009) (PubMed).

  • Antigène
    RPS6KA3 (Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 3 (RPS6KA3))
    Autre désignation
    RSK2 (RPS6KA3 Produits)
    Synonymes
    anticorps HU-1, anticorps MAPKAPK1A, anticorps RSK, anticorps RSK1, anticorps CLS, anticorps HU-3, anticorps ISPK-1, anticorps MAPKAPK1B, anticorps MRX19, anticorps RSK2, anticorps S6K-alpha3, anticorps p90-RSK2, anticorps pp90RSK2, anticorps MPK-9, anticorps Rsk2, anticorps RGD1563860, anticorps id:ibd1103, anticorps rps6ka3, anticorps si:ch211-114c12.12, anticorps wu:fk86e02, anticorps zgc:56006, anticorps zgc:158386, anticorps ribosomal protein S6 kinase A1, anticorps ribosomal protein S6 kinase A3, anticorps ribosomal protein S6 kinase polypeptide 3, anticorps ribosomal protein S6 kinase a, polypeptide 3a, anticorps ribosomal protein S6 kinase, polypeptide 3b, anticorps RPS6KA1, anticorps RPS6KA3, anticorps Rps6ka3, anticorps rps6ka3a, anticorps rps6ka3b
    Sujet

    Description: This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 non-identical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Mutations in this gene have been associated with Coffin-Lowry syndrome (CLS).

    Aliases: RPS6KA3, CLS, RSK, HU-3, RSK2, MRX19, ISPK-1, p90-RSK2, pp90RSK2, MAPKAPK1B, S6K-alpha3

    Poids moléculaire
    80 kDa
    ID gène
    6197
    HGNC
    6197
    Pathways
    Signalisation MAPK, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades
Support technique